Alerts will be sent to your verified email
Verify EmailBPLPHARMA
Bharat Parenterals
|
Sakar Healthcare
|
Shivalik Rasayan
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.41 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
12.73 % | 9.28 % | 7.33 % |
5yr average Equity Multiplier
|
1.76 | 1.75 | 1.84 |
5yr Average Asset Turnover Ratio
|
0.86 | 0.5 | 0.47 |
5yr Avg Net Profit Margin
|
8.73 % | 10.38 % | 8.37 % |
Price to Book
|
2.38 | 2.82 | 1.59 |
P/E
|
0.0 | 46.05 | 51.17 |
5yr Avg Cash Conversion Cycle
|
122.06 Days | -14.29 Days | 79.22 Days |
Inventory Days
|
46.56 Days | 46.75 Days | 63.09 Days |
Days Receivable
|
179.99 Days | 51.16 Days | 114.67 Days |
Days Payable
|
95.97 Days | 103.34 Days | 157.87 Days |
5yr Average Interest Coverage Ratio
|
22.68 | 5.43 | 10.93 |
5yr Avg ROCE
|
16.02 % | 10.08 % | 9.58 % |
5yr Avg Operating Profit Margin
|
11.16 % | 24.06 % | 18.09 % |
5 yr average Debt to Equity
|
0.26 | 0.47 | 0.16 |
5yr CAGR Net Profit
|
-9.67 % | 3.94 % | -1.91 % |
5yr Average Return on Assets
|
8.0 % | 5.37 % | 3.97 % |
Shareholdings
|
|||
Promoter Holding
|
67.2 % | 53.58 % | 47.37 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-6.64 % | -13.96 % | -2.95 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Bharat Parenterals
|
Sakar Healthcare
|
Shivalik Rasayan
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|